Abstract:AIMS Endothelial cell (EC) homeostasis plays an important role in normal physiological cardiac functions, and its dysfunction significantly influences pathological cardiac remodeling after myocardial infarction (MI). It has been shown that the sphingosine 1-phospahte receptor 1 (S1pr1) was highly expressed in ECs and played an important role in maintaining endothelial functions. We thus hypothesized that the endothelial S1pr1 might be involved in post-MI cardiac remodeling. METHODS AND RESULTS Our study showed that the specific loss of endothelial S1pr1 exacerbated post-MI cardiac remodeling and worsened cardiac dysfunction. We found that the loss of endothelial S1pr1 significantly reduced Ly6clow macrophage accumulation, which is critical for the resolution of inflammation and cardiac healing following MI. The reduced reparative macrophages in post-MI myocardium contributed to the detrimental effects of endothelial S1pr1 deficiency on post-MI cardiac remodeling. Further investigations showed that the loss of endothelial S1pr1 reduced Ly6clow macrophage proliferation, while the pharmacological activation of S1pr1 enhanced Ly6clow macrophage proliferation and thereby ameliorated cardiac remodeling after MI. A mechanism study showed that S1P/S1pr1 activated the ERK signaling pathway and enhanced colony stimulating factor 1 (CSF1) expression, which promoted Ly6clow macrophage proliferation in a cell-contact manner. The blockade of CSF1 signaling reversed the enhancing effect of S1pr1 activation on Ly6clow macrophage proliferation and worsened post-MI cardiac remodeling. CONCLUSIONS This study reveals that cardiac microvascular endothelium promotes reparative macrophage proliferation in injured hearts via the S1P/S1PR1/ERK/CSF1 pathway and thus ameliorates post-MI adverse cardiac remodeling. TRANSLATIONAL PERSPECTIVE This study highlights the importance of the local vascular microenvironment in orchestrating tissue inflammation and remodeling by regulating self-replenishment of tissue local reparative macrophages. Our studies demonstrate that ECs tightly control post-MI reparative Mo/Mϕ proliferation via the S1P/S1PR1/CSF1 pathway in a cell-contact manner. This implies that a feasible modulation of vascular niche signals might provide a promising target to resolve excessive inflammation and to ameliorate adverse cardiac remodeling after MI.

Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction

Theoretical Investigation Of The Mechanism Of Heart Failure Using A Canine Ventricular Cell Model: Especially The Role Of Up-Regulated Camkii And Sr Ca2+ Leak

The role of coronary microcirculation in heart failure with preserved ejection fraction: An unceasing odyssey

Microvascular Dysfunction across the Spectrum of Heart Failure Pathology: Pathophysiology, Clinical Features and Therapeutic Implications

Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis

Molecular mechanisms of endothelial dysfunction in coronary microcirculation dysfunction

Advances in extracardiac mechanisms for heart failure with preserved ejection fraction

Impact of coronary microvascular dysfunction in heart failure with preserved ejection fraction: a meta‐analysis

Prognostic Significance of Coronary Microvascular Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction.

Endothelial Autophagy in Coronary Microvascular Dysfunction and Cardiovascular Disease

Vascular Endothelial S1pr1 Ameliorates Adverse Cardiac Remodelling Via Stimulating Reparative Macrophage Proliferation after Myocardial Infarction.

Vascular dysfunction in HFpEF: Potential role in the development, maintenance, and progression of the disease

Bibliometric and visual analysis of coronary microvascular dysfunction

Cell Therapy and 3D Regenerative Tissue to Remodel Heart Failure

Endothelial Klf2-Foxp1-TGF signal mediates the inhibitory effects of simvastatin on maladaptive cardiac remodeling

Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF

Cellular and molecular pathobiology of heart failure with preserved ejection fraction

Endothelial Dysfunction and Heart Failure with Preserved Ejection Fraction-An Updated Review of the Literature

Recent advances in mechanistic studies of heart failure with preserved ejection fraction and its comorbidities-Role of microRNAs

Coronary microvascular dysfunction and cardiovascular disease: Pathogenesis, associations and treatment strategies

Endocardial Endothelial Dysfunction and Unknown Polymorphic Composite Accumulation in Heart Failure